(Q50798434)

19 March 2018

title

Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. (English)

1 reference

19 March 2018

1 reference

1 reference

S K Gupta

1

1 reference

19 March 2018

E H Ellinwood

series ordinal

2

1 reference

19 March 2018

A M Nikaido

series ordinal

3

1 reference

19 March 2018

D G Heatherly

series ordinal

4

1 reference

19 March 2018

publication date

1 April 1990

1 reference

19 March 2018

Journal of Pharmacokinetics and Pharmacodynamics

published in

1 reference

19 March 2018

volume

18

1 reference

19 March 2018

issue

2

1 reference

19 March 2018

page(s)

89-102

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/bf01063553

exact match

0 references

cites work

A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines.

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

The separation of 3H-Benzodiazepine binding sites in brain and of benzodiazepine pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Methods for Quantifying the transport of drugs across brain barrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

The effects of flurazepam, lorazepam, and triazolam on sleep and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Use of simple tasks to test for impairment of complex skills by a sedative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Dose-response analysis of the behavioral effects of diazepam: II. Psychomotor performance, cognition and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

JANA: a new iterative polyexponential curve stripping program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Benzodiazepine binding in human brain: Characterization using [3H] flunitrazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01063553

Pharmacokinetics of benzodiazepines. Short-acting versus long-acting

21 January 2018

1 reference

12 December 2020

Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam

1 reference

12 December 2020

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

12 December 2020

Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate

1 reference

12 December 2020

Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia

1 reference

12 December 2020

Evaluation of Instrumented Force Platform as a Test to Measure Residual Effects of Anesthetics

1 reference

12 December 2020

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

1 reference

12 December 2020

Simultaneous pharmacokinetic and pharmacodynamic modeling

1 reference

12 December 2020

Metabolism of lorazepam

1 reference

12 December 2020

Impaired performance and sedation after a single dose of lorazepam

1 reference

12 December 2020

Onset of peak impairment after diazepam and after alcohol

1 reference

12 December 2020

Pilot clinical trial of parenteral lorazepam (Temesta�) in anxiety states

1 reference

12 December 2020

Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam

1 reference

12 December 2020

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

1 reference

12 December 2020

Comparison of the actions of diazepam and lorazepam

1 reference

12 December 2020

Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

1 reference

12 December 2020

Benzodiazepines: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

Lorazepam: a review of its clinical pharmacological properties and therapeutic uses

1 reference

12 December 2020

Central nervous system and cardiovascular effects of lorazepam in man

1 reference

12 December 2020

Effects of lorazepam on memory, attention and sedation in man.

1 reference

12 December 2020

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

1 reference

12 December 2020

In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.

1 reference

12 December 2020

Estimation of variance for harmonic mean half-lives.

1 reference

12 December 2020

Dose tolerance to lorazepam develop with once weekly dosing?

1 reference

12 December 2020

Lorazepam-efficacy, side effects, and rebound phenomena

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01063553

1 reference

19 March 2018

PubMed ID

2348383

1 reference

19 March 2018